Report
KKR-owned Healthium and Temasek-backed Romsons reportedly vie for a 70–80% stake in BL Lifesciences
The Economic Times reports BL Lifesciences is likely to be valued at ₹1,800–2,000 crore in the proposed sale.
TLDR
The Economic Times reports, citing people aware of the development, that Healthium Medtech and Romsons Group are the major contenders for about 70–80% of Delhi-based BL Lifesciences. Those people said the medical-devices company is likely to be valued at ₹1,800–2,000 crore. KPMG is advising its promoters on the stake sale.
Combined views
2.9K
1 Source, first seen ago